Государственное Учреждение "Институт Геронтологии" Амн Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Геронтологии" Амн УкраиныfiledCriticalГосударственное Учреждение "Институт Геронтологии" Амн Украины
Priority to UAU201002357UpriorityCriticalpatent/UA49534U/en
Publication of UA49534UpublicationCriticalpatent/UA49534U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for optimizing the treatment of the heart failure in the aged patients after myocardial infarction provides for the basic therapy with acetylsalicylic acid at a dose of 100 mg/day. When the activation of coagulation system is evident, namely D-dimers increase above 100 ng/mL and SFMC above 4 mg / 100 mL, acetylsalicylic acid is replaced by Varfarin at a dose required for maintaining international normalized ratio within 2.0-3.0.
UAU201002357U2010-03-022010-03-02Method for optimizing treatment of heart failure in aged patients after myocardial infarction
UA49534U
(en)
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation